Comparison of Cytotoxic Aldehyde Generation in Beta-Thalassemia Patients Chelated with Deferoxamine or Deferiprone (L1) Versus NO Chelation

References

• Lynch, S. R. (1995). Iron overload: prevalence and impact on health. Nutr. Rev., 53, 255–260.
   PubMed Web of Science ®Google Scholar
• Aldouri, M. A., Hoffbrand, A. V., Flynn, D. M., Ward, S. E., Agnew, J. E. and Hilson, A. J. W. (1994). High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusions and chelation: reversal by intensified chelation. Acta. Haematol., 84, 113–123.
   Google Scholar
• Herbert, V., Shaw, S., Jayatilleke, E. and Stopler-Kasdan, T. (1994). Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells, 12, 289–303.
   PubMed Web of Science ®Google Scholar
• Lesnefsky, E. J. (1994). Tissue iron overload and mechanisms of iron-catalyzed oxidative injury. Adv. Exp. Med. Biol., 366, 129–146.
   PubMedGoogle Scholar
• Halliwell, B. and Gutteridge, J. M. C. (1990). Role of free radicals and catalytic metal ions in human disease. An overview. Meth. Enzymol., 186, 1–85.
   PubMed Web of Science ®Google Scholar
• Burkitt, M. J., Kadiiska, M. B., Hanna, P. M., Jordan, S. J. and Mason, R. P. (1992). Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation duringacute iron poisoning. Mol. Pharmacol., 43, 257–263.
   Web of Science ®Google Scholar
• Burkitt, M. J. and Mason, R. P. (1991). Direct evidence for in vivo hydroxyl radical generation in experimental iron overload: an ESR spin-trapping investigation. Proc. Natl. Acad. Sci. U.S.A., 88, 8440–8444.
   PubMed Web of Science ®Google Scholar
• Kang, J. O., Slivka, A., Slater, G. and Cohen, G. (1989). In vivo formation of hydroxyl radicals following intragastric administration of ferrous salts in rats. J. Inorg. Biochem., 35, 55–69.
   PubMed Web of Science ®Google Scholar
• Scott, M. D., van den Berg, J. J. M., Repka, T., Rouyer-Fessard, P., Hebbel, R. P., Beuzard, Y. and Lubin, B. H. (1993). Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassaemic erythrocytes. J. Clin. Invest., 91, 1706–1712.
   PubMed Web of Science ®Google Scholar
• Shinar, E. and Rachmilewitz, E. A. (1990). Oxidative denaturation of red blood cells in thalassemia. Semin. Hematol., 27, 70–82.
   PubMed Web of Science ®Google Scholar
• Grinberg, L. N., Rachmilewitz, E. A., Kitrossky, N. and Chevion, M. (1995). Hydroxyl radical generation in β-thalassemic red blood cells. Free Radio. Biol. Med., 18, 611–615.
   PubMed Web of Science ®Google Scholar
• Repka, T. and Hebbel, R. P. (1991). Hydroxyl radical formation by sickle erythrocyte membranes: Role of pathologic iron deposits and cytoplasmic reducing agents. Blood, 78, 2753–2758.
   PubMed Web of Science ®Google Scholar
• Brunori, M. G., Falcioni, E., Fioretti, E., Giardina, B. and Rotilio, G. (1975). Formation of superoxide in the autooxidation of the isolated α- and β-chains of human hemoglobin and its involvement in hemichrome precipitation. Eur. J. Biochem., 53, 99–104.
   Google Scholar
• Bartfay, W. J., Dawood, F., Wen, W. H., Lehotay, D. C., Hou, D., Bartfay, E., Luo, X. P., Backx, P. H. and Liu, P. P. (1999). Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload. Cardiovasc. Res., (in press).
   Google Scholar
• Houglum, K., Filip, M., Witzutum, B. and Choiker, M. (1990). Malondialdehyde and 4-hydroxynoneal protein adducts in plasma and liver of rat with iron overload. J. Clin. Invest., 86, 1991–1998.
   PubMed Web of Science ®Google Scholar
• Young, I. S., Trouton, T. G., Tomey, J. J., McMaster, D., Callender, M. and Trimble, E. R. (1994). Antioxidant status and lipid peroxidation in hereditary hemochromatosis. Free Radio. Biol. Med., 16, 393–397.
   PubMed Web of Science ®Google Scholar
• Gutteridge, J. M. C., Rowley, D. A., Griffiths, E. and Halliwell, B. (1985). Low-molecular-weight ironcomplexes and oxygen radical reactions in idiopathic haemochromatosis. Clin. Sci., 68, 463–467.
   PubMed Web of Science ®Google Scholar
• Livrea, M. A., Tesoriere, L., Pintaudi, A. M., Calabrese, A., Maggio, A., Freisleben, H. J., D-Arpa, D., D'Anna, R. and Bongiomo, A. (1996). Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood, 88, 3608–3614.
   PubMed Web of Science ®Google Scholar
• Jewell, A. P. and Marcus, R. E. (1984). Platelet derived malondialdehyde production in patients with thalassemia major. J. Clin. Pathol., 37, 1043–1045.
   PubMed Web of Science ®Google Scholar
• Ursini, F. and Bindoli, A. (1987). The role of selenium in the protection of membranes against oxidative damage of membranes. Chem. Phys. Lipids, 44, 255–276.
   PubMed Web of Science ®Google Scholar
• Hill, K. E. and Burke, R. F. (1984). Influence of vitamin E and selenium on glutathione-dependent protection against microsomal lipid peroxidation. Biochem. Pharmacol., 33, 1065–1068.
   PubMed Web of Science ®Google Scholar
• Brittenham, G. M., Farrell, D. E., Harris, J. W., Feldman, E. S., Danish, E. H., Muir, W. A., Tripp, J. H. and Bellon, E. M. (1982). Magnetic-susceptibility measurement of human iron stores. New Engl. J. Med., 307, 1671–1675.
   PubMed Web of Science ®Google Scholar
• McMaster, D., Bell, N., Anderson, P. and Love, A. H. (1990). Automated measurement of two indicators of human selenium status, and applicability to population study. Clin. Chem., 36, 211–216.
   PubMed Web of Science ®Google Scholar
• Bartfay, W. J., Hou, D., Brittenham, G. M., Bartfay, E., Sole, M. J., Lehotay, D. C. and Liu, P. P. (1998). The synergistic effects of vitamin E and selenium in iron-loaded mouse hearts. Can. J. Cardiol., 14, 937–941.
   PubMed Web of Science ®Google Scholar
• Luo, X. P., Yazdanpanah, M., Bhooi, N. and Lehotay, D. C. (1995). Determination of aldehydes and otherlipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal. Biochem., 228, 294–298.
   PubMed Web of Science ®Google Scholar
• Esterbauer, H. (1993). Cytotoxicity and genotoxicity of lipid-peroxidation products. Am. J. Clin. Nutr., 57, 779S–786S.
   PubMed Web of Science ®Google Scholar
• Halliwell, B. and Chirico, S. (1993). Lipid peroxidation: its mechanism, measurement, and significance. Am. J. Clin. Nutr., 57, 715S–725S.
   PubMed Web of Science ®Google Scholar
• Cheeseman, K. H. (1993). Mechanisms and effects of lipid peroxidation. Mol. Aspects Med., 14, 191–197.
   PubMed Web of Science ®Google Scholar
• Benedetti, A., Casini, A. F., Ferrali, M. and Comporti, M. (1979). Effects of diffusible products of peroxidation on rat liver microsomal lipids. Biochem. J., 180, 303–312.
   PubMed Web of Science ®Google Scholar
• Kozlov, A. B., Ostrachovitch, E. A. and Afanas'ev, I. B. (1994). Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates. Biochem. Pharmacol., 47, 795–799.
   PubMed Web of Science ®Google Scholar
• Menasche, P., Grousset, C., Gaudel, Y., Mouas, C. and Piwnica, A. (1987). Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Protective effects of deferoxamine. Circulation, 76(V), 906–915.
   PubMedGoogle Scholar
• Olivieri, N. F. and Brittenham, G. M. (1997). Iron-chelating therapy and the treatment of thalassemia.Blood, 89, 281–284.
   PubMed Web of Science ®Google Scholar
• Hoffbrand, A. V. (1995). Iron chelation therapy. Curr. Opin. Hematol., 2, 153–158.
   PubMedGoogle Scholar
• Mostert, L. J., Van Dorst, J. A., Koster, J. F., van Eijk, H. G. and Kontoghiorghes, G. J. (1987). Free radical and cytotoxic effects of chelators and their iron complexes in hepatocyte. Free Radic. Res. Commun., 3, 379–388.
   Google Scholar
• Loebstein, R., Lehotay, D. C., Lou, X. P., Bartfay, W., Tyler, B. and Sher, G. D. (1998). Diabetic nephropathy in hypertransfused patients with β-thalassemia: The role of oxidative stress. Diabetes Care, 21, 1306–1309.
   PubMed Web of Science ®Google Scholar
• Shalev, O., Repka, T., Goldfarb, A., Grinberg, L., Abrahamov, A., Oliveri, N. F., Rachmilewitz, E. A. and Hebbel, R. P. (1995). Deferiprone (L1) chelates pathologic iron deposits from membrane of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood, 86, 2008–2013.
   PubMed Web of Science ®Google Scholar
• Bannister, J. V., Bannister, W. H. and Thomalley, D. (1984). The effect of ferritin iron loading on hydroxyl radical production. Life Chem. Rep., 84(2), 64–72.
   Google Scholar
• Carlin, G. and Djursater, R. (1984). Xanthine oxidase induced depolymerization of hyaluronic acid in the presence of ferritin. FEBS Lett., 117, 27–30.
   Web of Science ®Google Scholar
• Grootveld, M., Bell, J. D., Halliwell, B., Aruoma, O. I., Bomford, A. and Sadler, P. J. (1989). Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. J. Biol. Chem., 264, 4417–4422.
   PubMed Web of Science ®Google Scholar
• Hershko, C., Graham, G., Bates, G. W. and Rachmilewitz, E. A. (1978). Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br. J. Haematol., 40, 255–263.
   PubMed Web of Science ®Google Scholar
• Wagstaff, M., Peters, S. W., Jones, B. M. and Jacobs, A. (1986). Free-iron and iron toxicity in iron overload. Br. J. Haematol., 67, 566–567.
   Google Scholar
• Wang, W. C., Ahmed, N. and Hanna, M. (1986). Non-transferrin-bound iron in long-term transfusion in children with congenital anemias. J. Pediatr., 108, 552–557.
   PubMed Web of Science ®Google Scholar
• Al-Refaie, F. N., Wickens, D. G., Wonke, B., Konto-ghiorghes, G. J. and Hoffbrand, A. V. (1992). Serumnon-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1. Br. J. Haematol., 82, 431–436.
   PubMed Web of Science ®Google Scholar
• Craven, C. M., Alexander, J., Eldridge, M., Kusher, J. P., Berstein, S. and Kaplan, J. (1987). Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for haemochromatosis. Proc. Natl. Acad. Sci. U.S.A., 84, 3457–3461.
   PubMed Web of Science ®Google Scholar
• Link, G., Pinson, A. and Hershko, C. H. (1985). Heart cells in culture: a model of myocardial iron overload and chelation. J. Lab. Clin. Med., 106, 147–153.
   PubMed Web of Science ®Google Scholar
• Ahmed, N. K., Hanna, M. and Wang, W. (1986). Non-transferrin-bound iron in thalassemia and sickle cell patients. Int. J. Biochem., 18, 953–956.
   PubMedGoogle Scholar
• Zanninelli, G., Choudury, R., Loreal, O., Guyader, D., Lescoat, G., Arnaud, J., Verna, R., Cosson, B., Singh, S., Hider, R. C. and Brissot, P. (1997). Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats. J. Hepatol., 27, 176–184.
   PubMed Web of Science ®Google Scholar
• Starke, P. E. and Faber, J. L. (1985). Ferric iron and superoxide ions are required for the killing of cultured hepatocytes by hydrogen peroxide-evidenced for the participation of hydroxyl radicals formed by iron-catalyzed Haber Weiss reaction. J. Biol. Chem., 260, 10099–10104.
   PubMed Web of Science ®Google Scholar
• Byler, R. M., Sherman, N. A., Wallner, J. S. and Horwitz, L. D. (1994). Hydrogen peroxide cytotoxicityis iron dependent. Am. J. Physiol. (Heart Circ. Physiol.), 35, H121–H127.
   Google Scholar
• Samuni, A., Winkelsberg, D., Pinson, A., Hahn, S. M., Mitchell, J. B. and Russo, A. (1991). Nitroxide stable radicals protects beating cardiomyocytes against oxidative damage. J. Clin. Invest., 87, 526–530.
   Web of Science ®Google Scholar
• Grelloni, F., Gabbianelli, R., Santroni, A. M. and Falcioni, G. (1993). Inactivation of glutathione peroxidase following entrapment of purified alpha or beta hemoglobin chains in human erythrocytes. Clin. Chim. Acta,217, 187–192.
   PubMed Web of Science ®Google Scholar
• Brenneisen, P., Briviba, K., Wlaschek, M., Wenk, J. and Scharffetter-Kochanenk, K. (1997). Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic. Biol. Med., 22, 515–524.
   PubMed Web of Science ®Google Scholar
• Ben-Yoseph, O., Boxer, P. A. and Ross, B. D. (1994). Oxidative stress in the central nervous system: monitoring the metabolic response using the pentose phosphate pathway. Dev. Neurosci., 16, 328–336.
   PubMed Web of Science ®Google Scholar
• Pucheu, S., Coudray, C., Tresallet, N., Favier, A. and de Leiris, J. (1993). Effect of iron overload in the isolated and reperfused rat heart. Cardiovasc. Drugs Ther., 7, 701–711.
   PubMed Web of Science ®Google Scholar